Nan Liu
Nan Liu
1Cancer and Blood Disorders Center, Dana Farber Cancer
Institute and Boston Children’s Hospital, Harvard Medical School, Boston,
Massachusetts, USA
7These authors contributed equally
1,7,
Shuqian Xu
Shuqian Xu
1Cancer and Blood Disorders Center, Dana Farber Cancer
Institute and Boston Children’s Hospital, Harvard Medical School, Boston,
Massachusetts, USA
2Department of Hematology, Qilu Hospital, Cheeloo College of
Medicine, Shandong University, Jinan, China
7These authors contributed equally
1,2,7,
Qiuming Yao
Qiuming Yao
1Cancer and Blood Disorders Center, Dana Farber Cancer
Institute and Boston Children’s Hospital, Harvard Medical School, Boston,
Massachusetts, USA
3Molecular Pathology Unit & Center for Cancer Research,
Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts,
USA
1,3,
Qian Zhu
Qian Zhu
4Department of Pediatric Oncology, Dana Farber Cancer
Institute and Harvard Medical School, Boston, Massachusetts, USA
4,
Yan Kai
Yan Kai
4Department of Pediatric Oncology, Dana Farber Cancer
Institute and Harvard Medical School, Boston, Massachusetts, USA
4,
Jonathan Y Hsu
Jonathan Y Hsu
3Molecular Pathology Unit & Center for Cancer Research,
Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts,
USA
3,
Phraew Sakon
Phraew Sakon
1Cancer and Blood Disorders Center, Dana Farber Cancer
Institute and Boston Children’s Hospital, Harvard Medical School, Boston,
Massachusetts, USA
1,
Luca Pinello
Luca Pinello
3Molecular Pathology Unit & Center for Cancer Research,
Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts,
USA
3,
Guo-Cheng Yuan
Guo-Cheng Yuan
4Department of Pediatric Oncology, Dana Farber Cancer
Institute and Harvard Medical School, Boston, Massachusetts, USA
5Present address: Department of Genetics and Genomic
Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA
4,5,
Daniel E Bauer
Daniel E Bauer
1Cancer and Blood Disorders Center, Dana Farber Cancer
Institute and Boston Children’s Hospital, Harvard Medical School, Boston,
Massachusetts, USA
1,
Stuart H Orkin
Stuart H Orkin
1Cancer and Blood Disorders Center, Dana Farber Cancer
Institute and Boston Children’s Hospital, Harvard Medical School, Boston,
Massachusetts, USA
6Howard Hughes Medical Institute, Boston, Massachusetts,
USA
1,6
1Cancer and Blood Disorders Center, Dana Farber Cancer
Institute and Boston Children’s Hospital, Harvard Medical School, Boston,
Massachusetts, USA
2Department of Hematology, Qilu Hospital, Cheeloo College of
Medicine, Shandong University, Jinan, China
3Molecular Pathology Unit & Center for Cancer Research,
Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts,
USA
4Department of Pediatric Oncology, Dana Farber Cancer
Institute and Harvard Medical School, Boston, Massachusetts, USA
5Present address: Department of Genetics and Genomic
Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA
6Howard Hughes Medical Institute, Boston, Massachusetts,
USA
7These authors contributed equally
✉Corresponding Author: Stuart H. Orkin
(stuart_orkin@dfci.harvard.edu)